SCM
BLTE

Soleus Capital Management’s Belite Bio BLTE Stock Holding History

Soleus Capital Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.78M Buy
+50,524
New +$7.74M 0.27% 66
2026
Q1 		– Sell
-40,354
Closed -$6.46M – 96
2025
Q4 		$6.46M Sell
40,354
-169,646
-81% -$20.1M 0.24% 62
2025
Q3 		$15.5M Buy
+210,000
New +$13.8M 0.78% 34

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Soleus Capital Management's BLTE Position: Q2 2026 in Review

Soleus Capital Management opened a new position in Belite Bio (BLTE) in Q2 2026: 50,524 shares worth $7.78M. The stake represents 0.27% of the portfolio and ranks #66 among its holdings. This is a return to the name: Soleus Capital Management previously reported a position in BLTE as recently as Q4 2025.

Soleus Capital Management first reported a position in BLTE in Q3 2025 and has held it in 3 quarters since. The position peaked at $15.5M in Q3 2025. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Soleus Capital Management held 50,524 shares of Belite Bio worth $7.78M as of Q2 2026.
  • Belite Bio was a new Soleus Capital Management position in Q2 2026.
  • Belite Bio made up 0.27% of Soleus Capital Management's portfolio in Q2 2026, its #66 holding.
  • Soleus Capital Management first reported a position in Belite Bio in Q3 2025 and has held it in 3 quarters since.
  • Soleus Capital Management's Belite Bio position peaked at $15.5M in Q3 2025.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.